The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Sep. 23, 2014

Filed:

Mar. 24, 2011
Applicants:

Amr Salahieh, Saratoga, CA (US);

Alan Schaer, San Jose, CA (US);

Jeff Krolik, Campbell, CA (US);

John Spiridigliozzi, San Mateo, CA (US);

Suresh Pai, Mountain View, CA (US);

Tom Saul, El Granada, CA (US);

Inventors:

Amr Salahieh, Saratoga, CA (US);

Alan Schaer, San Jose, CA (US);

Jeff Krolik, Campbell, CA (US);

John Spiridigliozzi, San Mateo, CA (US);

Suresh Pai, Mountain View, CA (US);

Tom Saul, El Granada, CA (US);

Assignee:

Shifamed Holdings, LLC, Campbell, CA (US);

Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61M 31/00 (2006.01); A61M 29/00 (2006.01); A61M 1/00 (2006.01); A61M 5/00 (2006.01); A61M 25/00 (2006.01); A61M 25/10 (2013.01); A61M 25/04 (2006.01); A61M 25/06 (2006.01);
U.S. Cl.
CPC ...
A61M 25/0068 (2013.01); A61M 25/0054 (2013.01); A61M 25/1002 (2013.01); A61M 2025/0096 (2013.01); A61M 25/0082 (2013.01); A61M 25/0075 (2013.01); A61M 25/0074 (2013.01); A61M 25/04 (2013.01); A61M 2025/0681 (2013.01); A61M 25/008 (2013.01); A61M 2025/0079 (2013.01); A61M 2025/1097 (2013.01); A61M 25/0097 (2013.01);
Abstract

Disrupting tissue and devices and systems for disrupting tissue. The disclosure describes ways to deliver moieties to a target tissue, where the target tissue in general is not at the point of introduction, in such a way that minimal damage is produced in the tissue at the point of introduction. In some embodiments this is accomplished by jetting fluid at high velocity into the target tissue. The disclosure further describes novel agents deliverable in such systems for use in remodeling tissues. Some of these agents comprise a liquid while others do not. Additionally, although not specifically described in detail much of the disclosure may additionally be used in the delivery of therapeutic drugs.


Find Patent Forward Citations

Loading…